Hardy Reed’s Repligen RGEN Stock Holding History

Hardy Reed’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,877	Closed	-$233K	–	258
2025 Q2	$233K	Buy	1,877 +40	+2%	+$5.09K	0.02%	220
2025 Q1	$234K	Hold	1,837	–	–	0.02%	212
2024 Q4	$264K	Hold	1,837	–	–	0.02%	204
2024 Q3	$273K	Hold	1,837	–	–	0.02%	203
2024 Q2	$232K	Buy	1,837 +577	+46%	+$90.4K	0.02%	209
2024 Q1	$232K	Buy	+1,260	New	+$240K	0.03%	107
2021 Q4	–	Sell	-790	Closed	-$228K	–	109
2021 Q3	$228K	Buy	+790	New	+$203K	0.04%	93

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Hardy Reed's RGEN Position: Q3 2025 in Review

Hardy Reed sold out of Repligen (RGEN) in Q3 2025, closing a stake of 1,877 shares — an estimated $233K sold.

Hardy Reed first reported a position in RGEN in Q3 2021 and held it in 7 quarters. The position peaked at $273K in Q3 2024. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

Hardy Reed reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
Hardy Reed sold 1,877 Repligen shares in Q3 2025, an estimated $233K.
Hardy Reed first reported a position in Repligen in Q3 2021 and held it in 7 quarters.
Hardy Reed's Repligen position peaked at $273K in Q3 2024.
453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Hardy Reed's 13F filing for Q3 2025, filed 7 Nov 2025.